Fibrinolytic activity in patients with diabetes mellitus: characterization of the effects of thrombolytic agents on plasma clot lysis in vitro.
Fears
R
R
SmithKline Beecham Pharmaceuticals, Epsom, Surrey, UK.
Standring
R
R
Abraham
R
R
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001780:Blood Coagulation Tests; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control*; D012307:Risk Factors
D005343:Fibrinolytic Agents